Found 5 matching trials
Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab PHASE1 This study will be conducted to compare the pharmacokinetic (PK) exposure a...
Show More Learn More & Join Trial
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus PHASE3 The purpose of this study is evaluating the efficacy and safety of SC antif...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus PHASE2 The purpose of this study is to characterize the pharmacokinetics (PK), pha...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus PHASE3 This study aims to evaluate the efficacy and safety of subcutaneous (SC) an...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV) PHASE1 The purpose of this study is to assess the PK, PD, and safety of anifroluma...
Show More Location
Multiple Locations
Learn More & Join Trial